Literature DB >> 11465867

Anti-Smoking therapies: is harm reduction a viable alternative to smoking cessation?

J P Zellweger1.   

Abstract

Smoking cessation should be proposed to all smokers by healthcare workers; however, severely dependent smokers are frequently unable or unwilling to quit smoking. For some of them, particularly if they have failed in previous cessation attempts and have smoking-related disorders, a long term reduction of tobacco consumption may be proposed as the 'second best' attitude and may offer a perspective for reduction of some of the risk factors associated with smoking. This attitude, which cannot be regarded as a general health policy, usually requires the prolonged use of nicotine replacement therapy. From available studies, it does not seem that a period of sustained smoking reduction decreases the chance of future cessation, it may even increase it.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465867     DOI: 10.2165/00003495-200161080-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  16 in total

1.  Ability of smokers to reduce their smoking and its association with future smoking cessation.

Authors:  J R Hughes; K M Cummings; A Hyland
Journal:  Addiction       Date:  1999-01       Impact factor: 6.526

2.  The low tar lie.

Authors:  N R Leavell
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

3.  Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers.

Authors:  S I Rennard; D Daughton; J Fujita; M B Oehlerking; J R Dobson; M G Stahl; R A Robbins; A B Thompson
Journal:  Eur Respir J       Date:  1990-07       Impact factor: 16.671

4.  The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change.

Authors:  C C DiClemente; J O Prochaska; S K Fairhurst; W F Velicer; M M Velasquez; J S Rossi
Journal:  J Consult Clin Psychol       Date:  1991-04

5.  The emerging market for long-term nicotine maintenance.

Authors:  K E Warner; J Slade; D T Sweanor
Journal:  JAMA       Date:  1997-10-01       Impact factor: 56.272

6.  A meta-evaluation of smoking cessation intervention research among pregnant women: improving the science and art.

Authors:  R A Windsor; N R Boyd; C T Orleans
Journal:  Health Educ Res       Date:  1998-09

7.  Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.

Authors:  R D Hurt; G A Croghan; T D Wolter; I T Croghan; K P Offord; G M Williams; M V Djordjevic; J P Richie; A M Jeffrey
Journal:  Nicotine Tob Res       Date:  2000-11       Impact factor: 4.244

8.  Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia.

Authors:  G W Dalack; J H Meador-Woodruff
Journal:  Nicotine Tob Res       Date:  1999-03       Impact factor: 4.244

9.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

10.  Transdermal nicotine: reduction of smoking with minimal abuse liability.

Authors:  W B Pickworth; E B Bunker; J E Henningfield
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

View more
  1 in total

Review 1.  The feasibility of smoking reduction: an update.

Authors:  John R Hughes; Matthew J Carpenter
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.